Isofol's board appoints Dr. Jarl Ulf Jungnelius as new CEO of the company
GOTHENBURG, Sweden, November 13, 2019 – Isofol Medical AB (publ), (Nasdaq First North Premier: ISOFOL), today announced that the board of Isofol has decided that from today’s date, November 13 2019, appoint the chairman of the board, Dr Jarl Ulf Jungnelius, M.D., as CEO of the company. Consequently, Ulf Jungnelius steps down from his position as chairman of the board. Until the next AGM, Pär-Ola Mannefred will assume the role of chairman. As of this date, the present CEO, Anders Rabbe, is thereby relieved of his duties.Isofol is presently in a phase where it is crucial to ensure a high